We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $111M
1-Year Est. Return 74.4%
This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
-74.4%
3 Year Est. Return
-95.55%
5 Year Est. Return
-99.44%
10 Year Est. Return
-99.5%
AUM
$241M
AUM Growth
-$120M
Cap. Flow
+$14.3M
Cap. Flow %
5.93%
Top 10 Hldgs %
81.75%
Holding
117
New
44
Increased
16
Reduced
22
Closed
31

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.07%
2 Healthcare 8.45%
3 Technology 0.29%
4 Financials 0.15%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHIPZ
76
DELISTED
Seanergy Maritime Holdings Corp Class B Warrant
SHIPZ
$45K 0.02%
897,499
-10,500
-1% -$729
DMK
77
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$32K 0.01%
+1,260
New +$53.5K
TLPH icon
78
PUT
Talphera
TLPH
$64.4M
$26K 0.01%
+11
New +$336
TOVX icon
79
Theriva Biologics
TOVX
$10.8M
$25K 0.01%
308
-2,441
-89% -$278K
MDGSW
80
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$22K 0.01%
1,007,444
-1,000
-0.1% -$359
TEUM
81
PUT
DELISTED
Pareteum Corporation
TEUM
$21K 0.01%
+572
New +$341
TENX icon
82
Tenax Therapeutics
TENX
$69.6M
$19K 0.01%
21
-6
-22% -$10.5K
RBZ
83
DELISTED
Reebonz Holding Limited Ordinary Shares
RBZ
$10K ﹤0.01%
25,000
NSPR icon
84
InspireMD
NSPR
$37M
$7K ﹤0.01%
736
-15,931
-96% -$230K
SINT icon
85
SiNtx Technologies
SINT
$12M
$7K ﹤0.01%
+1
New +$19.9K
INDP icon
86
CALL
Indaptus Therapeutics
INDP
$418M
0
ABEO icon
87
Abeona Therapeutics
ABEO
$310M
-2,414
Closed -$197K
ALT icon
88
Altimmune
ALT
$642M
-44,855
Closed -$103K
AMRN
89
PUT
Amarin Corp
AMRN
$291M
-102
Closed -$4.39M
BIIB icon
90
CALL
Biogen
BIIB
$32.1B
-28
Closed -$831K
CRVO icon
91
CervoMed
CRVO
$38.9M
-14,473
Closed -$500K
GNPX icon
92
Genprex
GNPX
$2.75M
-10
Closed -$1.03M
IMNN icon
93
Imunon
IMNN
$8.25M
-350
Closed -$117K
IMNN icon
94
PUT
Imunon
IMNN
$8.25M
-1
Closed -$31K
IONS icon
95
CALL
Ionis Pharmaceuticals
IONS
$8.55B
-2,961
Closed -$17.9M
LPCN icon
96
Lipocine
LPCN
$18.7M
-21,629
Closed -$142K
MBOT icon
97
Microbot Medical
MBOT
$97.4M
-76,000
Closed -$773K
OGEN icon
98
Oragenics
OGEN
$2.16M
-195
Closed -$184K
CNSY
99
Cerenome
CNSY
$17.6M
-624
Closed -$562K
PULM icon
100
Pulmatrix
PULM
$5.15M
-22,337
Closed -$384K

Similar funds

Sabby Management's Q1 2020 Portfolio in Review

As of Q1 2020, Sabby Management held 117 positions worth $241M, down 33% from $361M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Sabby Management deployed $14.3M of net new capital in Q1 2020, opening 44 new positions and adding to 16 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 34,410 shares worth $3.05M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 94% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was SPDR Gold Trust, an estimated $2.92M trimmed.

  • Sabby Management's largest Q1 2020 buy was State Street Health Care Select Sector SPDR ETF: 34,410 shares worth $3.05M.
  • Sabby Management added most to Outlook Therapeutics in Q1 2020, an estimated $2.36M increase.
  • Sabby Management's biggest Q1 2020 reduction was SPDR Gold Trust, cutting an estimated $2.92M.
  • Sabby Management fully exited Traws Pharma in Q1 2020, selling an estimated $3.35M.
  • Sabby Management's ten largest holdings make up 82% of its $241M portfolio in Q1 2020.
  • Sabby Management opened 44 new positions and closed 31 in Q1 2020.
  • Sabby Management's portfolio value fell 33% quarter-over-quarter to $241M.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.